Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Evans

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Diabetes & Vascular Disease Research|December 19, 2023
Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysisMarc Evans, Paul Kuodi, Chisom Joyqueenet Akunna, et al.
Diabetes, Obesity & Metabolism|November 7, 2022
The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetesMarc Evans, Sasha Berry, Avideh Nazeri, et al.
Journal of Medical Economics|August 31, 2018
Development of a health economic model to evaluate the potential benefits of optimal serum potassium management in patients with heart failureAmeet Bakhai, Eirini Palaka, Cecilia Linde, et al.
Health and Quality of Life Outcomes|June 5, 2013
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countriesMarc Evans, Kamlesh Khunti, Muhammad Mamdani, et al.
BMC Nephrology|February 2, 2019
The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney diseaseMarc Evans, Eirini Palaka, Hans Furuland, et al.
Diabetes, Obesity & Metabolism|January 20, 2025
Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff modelPhil McEwan, Volker Foos, Geraint Roberts, et al.
Health and Quality of Life Outcomes|January 24, 2016
Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off studyMartin Ridderstråle, Lyndon Marc Evans, Henrik Holm Jensen, et al.
Animal Cognition|September 19, 2013
Validation of a novel cognitive bias task based on difference in quantity of reinforcement for assessing environmental enrichmentHeidi A Keen, O Lynne Nelson, Charles T Robbins, et al.
Clinical Therapeutics|March 15, 2011
Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database studyChristopher Ll Morgan, Marc Evans, Anders D Toft, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 20, 2020
What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right PatientW David Strain, Carmen Tsang, Michael Hurst, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Diabetes & Vascular Disease Research|December 19, 2023
Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysisMarc Evans, Paul Kuodi, Chisom Joyqueenet Akunna, et al.
Diabetes, Obesity & Metabolism|November 7, 2022
The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetesMarc Evans, Sasha Berry, Avideh Nazeri, et al.
Journal of Medical Economics|August 31, 2018
Development of a health economic model to evaluate the potential benefits of optimal serum potassium management in patients with heart failureAmeet Bakhai, Eirini Palaka, Cecilia Linde, et al.
Health and Quality of Life Outcomes|June 5, 2013
Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countriesMarc Evans, Kamlesh Khunti, Muhammad Mamdani, et al.
BMC Nephrology|February 2, 2019
The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney diseaseMarc Evans, Eirini Palaka, Hans Furuland, et al.
Diabetes, Obesity & Metabolism|January 20, 2025
Beyond glycated haemoglobin: Modelling contemporary management of type 2 diabetes with the updated Cardiff modelPhil McEwan, Volker Foos, Geraint Roberts, et al.
Health and Quality of Life Outcomes|January 24, 2016
Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off studyMartin Ridderstråle, Lyndon Marc Evans, Henrik Holm Jensen, et al.
Animal Cognition|September 19, 2013
Validation of a novel cognitive bias task based on difference in quantity of reinforcement for assessing environmental enrichmentHeidi A Keen, O Lynne Nelson, Charles T Robbins, et al.
Clinical Therapeutics|March 15, 2011
Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database studyChristopher Ll Morgan, Marc Evans, Anders D Toft, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 20, 2020
What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right PatientW David Strain, Carmen Tsang, Michael Hurst, et al.
Pageof 16